ConductScience.org, home

Paper30100549

Renaming low risk conditions labelled as cancer.

Nickel B and 4 others. BMJ, 2018. Cited by 35 papers, by iCite.

Cite this record

ConductScience Library. Renaming low risk conditions labelled as cancer. Papers, record 30100549. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30100549

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Renaming low risk conditions labelled as cancer.
PubMed
Journal
BMJ
PubMed
Year
2018
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
35
iCite
Relative citation ratio, by iCite
1.71
iCite
Revised in PubMed
2019-03-14
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nickel BBrooke
2Moynihan RRay
3Barratt AAlexandra
4Brito JPJuan P
5McCaffery KKirsten

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
Terminology as TopicMajor topic
Attitude to Health
Humans
Social Stigma

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.

PMIDTitleJournalYearIn PapersSource
39806624Impact of alternative diagnostic labels for melanoma in situ on management choices and psychological outcomes: protocol for an online randomised study.BMJ Open2024https://conductscience.org/library/papers/39806624PubMed
39420909Implementing active surveillance for low-risk thyroid carcinoma into clinical practice: collaborative recommendations for Latin America.Arch Endocrinol Metab2024https://conductscience.org/library/papers/39420909PubMed
39212985Cancer Care Terminology in African Languages.JAMA Netw Open2024https://conductscience.org/library/papers/39212985PubMed
39122400Impact of the diagnostic label for a low-risk prostate lesion: protocol for two online factorial randomised experiments.BMJ Open2024https://conductscience.org/library/papers/39122400PubMed
37838682Recruiting women with ductal carcinoma in situ to a randomised controlled trial: lessons from the LORIS study.Trials2023https://conductscience.org/library/papers/37838682PubMed
37478123Women's views about current and future management of Ductal Carcinoma in Situ (DCIS): A mixed-methods study.PLoS One2023https://conductscience.org/library/papers/37478123PubMed
37074481Should low-risk DCIS lose the cancer label? An evidence review.Breast Cancer Res Treat2023https://conductscience.org/library/papers/37074481PubMed
36889825Consequences of early thyroid ultrasound on subsequent tests, morbidity and costs: an explorative analysis of routine health data from German ambulatory care.BMJ Open2023https://conductscience.org/library/papers/36889825PubMed
36811453Low-risk prostate lesions: An evidence review to inform discussion on losing the "cancer" label.Prostate2023https://conductscience.org/library/papers/36811453PubMed
36568283Cancer overdiagnosis: a challenge in the era of screening.J Natl Cancer Cent2022https://conductscience.org/library/papers/36568283PubMed
35626380The Use of Digital Pathology and Artificial Intelligence in Histopathological Diagnostic Assessment of Prostate Cancer: A Survey of Prostate Cancer UK Supporters.Diagnostics (Basel)2022https://conductscience.org/library/papers/35626380PubMed
35099399Ethical Issues of Digital Twins for Personalized Health Care Service: Preliminary Mapping Study.J Med Internet Res2022https://conductscience.org/library/papers/35099399PubMed
35007335Do we need to rethink the diagnoses melanoma in situ and severely dysplastic naevus?Br J Dermatol2022https://conductscience.org/library/papers/35007335PubMed
33428025Overdiagnosis: one concept, three perspectives, and a model.Eur J Epidemiol2021https://conductscience.org/library/papers/33428025PubMed
32999857Screening for scoliosis - New recommendations, old dilemmas, no straight solutions.World J Orthop2020https://conductscience.org/library/papers/32999857PubMed
32690532Media coverage of calls to rename low-risk cancers: a content analysis.BMJ Open2020https://conductscience.org/library/papers/32690532PubMed
32313870The impact of the illness label 'gout' on illness and treatment perceptions in Māori (Indigenous New Zealanders).BMC Rheumatol2020https://conductscience.org/library/papers/32313870PubMed
30796581Expanding disease and undermining the ethos of medicine.Eur J Epidemiol2019https://conductscience.org/library/papers/30796581PubMed
30627960National consensus recommendations on patient-centered care for ductal carcinoma in situ.Breast Cancer Res Treat2019https://conductscience.org/library/papers/30627960PubMed
30361301The elusive diagnosis of cancer: testing times.Br J Gen Pract2018https://conductscience.org/library/papers/30361301PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30100549

GET https://conductscience.org/api/papers/v1/30100549/authors